Skip to content

Comparison between efficacy of trinapanchmoola kashaya and punarnava kashaya in mutradoshvikara with special reference to chronic kidney disease

A comparative clinical study to assess the efficacy of trinapanchmoola kashaya and punarnava kashaya in the management of mutradoshvikara w.s.r.to chronic kidney disease - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058497
Enrollment
30
Registered
2023-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Sponsors

Dr Sunil Thakur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of chronic kidney disease having blood urea 50 to 100 mg/dl, S. Creatinine 1.3 to 4.0 mg/dl and eGFR between 45 to 90 ml/min/1.73m2

Exclusion criteria

Exclusion criteria: Patients with advanced renal failure with b urea >100mg/dl and S creatinine >4.0 mg/dl Patients suffering from other major illness like carcinoma or PTB

Design outcomes

Primary

MeasureTime frame
A comparative clinical study to assess the efficacy of trinpanchmoola kashaya & punarnava kashaya in the management of mutradoshvikara w.s.r. to chronic kidney diseaseTimepoint: 12 weeks

Secondary

MeasureTime frame
To assess the clinical safety of trinapanchmoola kashaya & punarnava kashaya in the management of mutradoshvikara w s r to chronic kidney diseaseTimepoint: 12 weeks

Countries

India

Contacts

Public ContactMahima

Rajiv Gandhi Govt Post Graduate Ayurvedic College and hospital Paprola

dranjana269@gmail.com9418312324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026